SCHEMBL6990867

SCHEMBL6990867

[c]1cccc(-c2ccccn2)c1CNCCC1CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR39 O43194 5/20 0.36
AXL P30530 2/20 0.35
FLT3 P36888 2/20 0.35
TYRO3 Q06418 2/20 0.35
MERTK Q12866 2/20 0.35
GAS6 Q14393 2/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321221 0.88 GPR39 (0.42) GPR39AXLFLT3TYRO3MERTK
SCHEMBL6331061 0.78 GPR39 (0.41) GPR39AXLFLT3TYRO3MERTK
SCHEMBL6328543 0.78 GPR39 (0.39) GPR39AXLFLT3TYRO3MERTK
SCHEMBL6322319 0.73 MEN1 (0.37) GPR39ADRA1DADRA1AADRA1BMEN1
SCHEMBL7389446 0.69 HTR7 (0.39) ADRA1DADRA1AADRA1BNPC1CYP1A2
SCHEMBL8191562 0.69 KDM4E (0.39) AXLFLT3TYRO3MERTKGAS6
SCHEMBL6337574 0.68 KDM4E (0.38) ADRA1DADRA1AADRA1BNPC1CYP1A2
SCHEMBL7390599 0.68 HTR7 (0.40) MEN1CYP1A2GAAMAPTCYP2C19
SCHEMBL6641136 0.68 TGFBR1 (0.40) CYP1A2CYP2C19HTR7TGFBR1HIF1A
SCHEMBL6640607 0.67 MEN1 (0.42) MEN1CYP2D6CYP2C9CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed